A predictive model for risk of early grade ≥ 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trial-Reference-Cited by-同舟云学术

A predictive model for risk of early grade ≥ 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trial

Published:2018-04-26 Issue:6 Volume:32 Page:1404-1413
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Dumontet Charles,Hulin Cyrille,Dimopoulos Meletios A.,Belch Andrew,Dispenzieri Angela,Ludwig Heinz,Rodon Philippe,Van Droogenbroeck Jan,Qiu Lugui,Cavo Michele,Van de Velde Ann,Lahuerta Juan José,Allangba Olivier,Lee Jae Hoon,Boyle Eileen,Perrot Aurore,Moreau Philippe,Manier Salomon,Attal Michel,Roussel Murielle,Mohty Mohamad,Mary Jean Yves,Civet Alexandre,Costa Bruno,Tinel Antoine,Gaston-Mathé Yann,Facon Thierry

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-018-0133-x.pdf

Reference24 articles.

1. Nucci M, Anaissie E. Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents. Clin Infect Dis. 2009;49:1211–25.

2. Augustson BM, Begum G, Dunn JA, Barth NJ, Davies F, Morgan G, et al. Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002—Medical Research Council Adult Leukaemia Working Party. J Clin Oncol. 2005;23:9219–26.

3. Hsu P, Lin TW, Gau JP, Yu YB, Hsiao LT, Tzeng CH, et al. Risk of early mortality in patients with newly diagnosed multiple myeloma. Med (Baltim). 2015;94:e2305.

4. Blimark C, Holmberg E, Mellqvist UH, Landgren O, Bjorkholm M, Hultcrantz M, et al. Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients. Haematologica. 2015;100:107–13.

5. Ying L, YinHui T, Yunliang Z, Sun H. Lenalidomide and the risk of serious infection in patients with multiple myeloma: a systematic review and meta-analysis. Oncotarget. 2017;8:46593–600.

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple myeloma and infections in the era of novel treatment modalities;Leukemia Research;2024-08

2. The Challenging Approach to Multiple Myeloma: From Disease Diagnosis and Monitoring to Complications Management;Cancers;2024-06-19

3. Death Caused by Disseminated Herpes Zoster in a Patient with Multiple Myeloma: A Case Report and Literature Review;Clinical, Cosmetic and Investigational Dermatology;2024-04

4. Cost-effectiveness and budget impact analysis of Daratumumab, Lenalidomide and dexamethasone for relapsed-refractory multiple myeloma;Cost Effectiveness and Resource Allocation;2024-02-28

5. How I treat multiple myeloma in geriatric patients;Blood;2024-01-18